Ronald K Potkul, MD
Gynecologic Oncology, Obstetrics & Gynecology
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
(888)584-7888
Appointments (New Patients Welcome)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
(888)584-7888Services & Specialties
Areas of Specialization
- Gynecologic Oncology
- Obstetrics & Gynecology
Clinical Interests
Conditions Treated
- sentinel lymph node biopsy
- cervical and endometrial cancer surgery
- cervical and endometrial cancers
- Complex Pelvic Surgery
- Vaginal Cancer
- gestational trophoblastic disease
- minimally invasive gynecologic surgery
- ovarian cancer
- ovarian cancer surgery
- Robotic Gynecological Surgery
- gynecologic cancer surgery
- vulvar cancer
- leiomyosarcoma
- paget's disease of vulva
- radical vulvectomy
Locations & Contact
Primary Location
Loyola University Medical Center
2160 S First Ave
Maywood
, IL 60153
About
Academic Title
Professor
Leadership Title
Department Chairperson, Obstetrics and Gynecology
Ages Seen
Additional Resources
Education & Certifications
Education
Education:
University of Chicago Pritzker School of Medicine
(1981)
Internship:
University of Chicago Medical Center
(1982)
Residency:
University of Chicago Medical Center
(1985)
Fellowship:
Georgetown University Hospital
(1988)
Board Certifications
Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics & Gynecology Subspecialty (1990)
Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics and Gynecology Subspecialty (1990)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Publications
- Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Ross, D. H.; Gomez, K.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Goldberg, A.; Liotta, M.; Potkul, R.; Winder, A.; Lee, B.; Jackson, J.; Roeske, J. C.; Small, W.; Harkenrider, M. M.; Gynecologic oncology
- Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Stiff, P. J.; Mehrotra, S.; Potkul, R. K.; Banerjee, S.; Walker, C.; Drakes, M. L.; Cancers
- Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer. Buehner, T. M.; Liotta, M.; Potkul, R. K.; Wagner, R. H.; Savir-Baruch, B.; Molecular imaging and biology
- Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management. Small, W.; Kim, Y. S.; Joyce, C.; Surucu, M.; Leshyk, M.; Harkenrider, M. M.; Potkul, R. K.; Liotta, M.; Winder, A.; Altoos, B.; Brachytherapy
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Fukushiro-Lopes, D.; Hegel, A. D.; Russo, A.; Senyuk, V.; Liotta, M.; Beeson, G. C.; Beeson, C. C.; Burdette, J.; Potkul, R. K.; Gentile, S.; Frontiers in pharmacology
- Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity. McAlarnen, L. A.; Ryan, K.; Adams, W.; Gliniewicz, A.; Winder, A. D.; Liotta, M. R.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Gynecologic oncology reports
- Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients? Nieto, K.; Martin, B.; Pham, N.; Palmere, L.; Silva, S. R.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
- Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, M. L.; Mehrotra, S.; Aldulescu, M.; Potkul, R. K.; Liu, Y.; Grisoli, A.; Joyce, C.; O'Brien, T. E.; Stack, M. S.; Stiff, P. J.; Journal of ovarian research
- Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Kharouta, M. Z.; Pham, N.; Nieto, K.; Surucu, M.; Mysz, M. L.; Albuquerque, K.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
- Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program. Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W.; Brachytherapy
- Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S.; NPJ breast cancer
- How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer. Harkenrider, M. M.; Shea, S. M.; Wood, A. M.; Chinsky, B.; Bajaj, A.; Mysz, M.; Yacoub, J. H.; Goldberg, A.; Liotta, M.; Potkul, R.; Surucu, M.; Roeske, J.; Small, W.; Journal of contemporary brachytherapy
- Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman. Bahar, B.; Hu, Z.; Szpaderska, A.; Liotta, M.; Potkul, R. K.; Smith, D.; Erşahin, Ç.; International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
- Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Albuquerque, K.; Giangreco, D.; Morrison, C.; Siddiqui, M.; Sinacore, J.; Potkul, R.; Roeske, J.; International journal of radiation oncology, biology, physics
- Hepatic resection for recurrent metastatic ovarian cancer. Abood, G.; Bowen, M.; Potkul, R.; Aranha, G.; Shoup, M.; American journal of surgery
- FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast. Omeroglu, G.; Ersşahin, C.; Potkul, R. K.; Booth, C. N.; Diagnostic cytopathology
- Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia. Erşahin, C.; Omeroglu, G.; Potkul, R. K.; Salhadar, A.; Gynecologic oncology
- Mesonephric adenocarcinoma of the vagina with a 3-year follow-up. Erşahin, C.; Huang, M.; Potkul, R. K.; Hammadeh, R.; Salhadar, A.; Gynecologic oncology
- Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B.; Gynecologic oncology
- Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Wakabayashi, M. T.; Da Silva, D. M.; Potkul, R. K.; Kast, W. M.; Intervirology
- A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy. Small, L. A.; Da Silva, D. M.; de Visser, K. E.; Velders, M. P.; Fisher, S. G.; Potkul, R. K.; Kast, W. M.; Clinical cancer research : an official journal of the American Association for Cancer Research
- Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes. Contreras, D. N.; Krammer, P. H.; Potkul, R. K.; Bu, P.; Rossi, J. L.; Kaufmann, A. M.; Gissmann, L.; Qiao, L.; Journal of immunotherapy (Hagerstown, Md. : 1997)
- Sonographic assessment of an inaccessible chemotherapy infusion port. Kalbhen, C. L.; Salomon, C. G.; Contreras, D. N.; Smith, D. M.; Potkul, R. K.; AJR. American journal of roentgenology
- PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. Nieland, J. D.; Loviscek, K.; Kono, K.; Albain, K. S.; McCall, A. R.; Potkul, R. K.; Fisher, S. G.; Velders, M. P.; Petersson, M.; Kiessling, R.; Kast, W. M.; Journal of immunotherapy (Hagerstown, Md. : 1997)
- A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Irvin, W. P.; Price, F. V.; Bailey, H.; Gelder, M.; Rosenbluth, R.; Durivage, H. J.; Potkul, R. K.; Cancer
- Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice. Michelin, D.; Gissmann, L.; Street, D.; Potkul, R. K.; Fisher, S.; Kaufmann, A. M.; Qiao, L.; Schreckenberger, C.; Gynecologic oncology
- Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Street, D.; Kaufmann, A. M.; Vaughan, A.; Fisher, S. G.; Hunter, M.; Schreckenberger, C.; Potkul, R. K.; Gissmann, L.; Qiao, L.; Gynecologic oncology
- High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Stiff, P. J.; Bayer, R.; Kerger, C.; Potkul, R. K.; Malhotra, D.; Peace, D. J.; Smith, D.; Fisher, S. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Reply. Delgado, G.; Potkul, R. K.; Gynecologic oncology
- Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Erlich, E.; McCall, A. R.; Potkul, R. K.; Walter, S.; Vaughan, A.; Gynecologic oncology
- The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. McCall, A. R.; Olson, M. C.; Potkul, R. K.; Cancer
- Retroperitoneal radical hysterectomy. Delgado, G.; Potkul, R. K.; Dolan, J. R.; Gynecologic oncology
- Vulvar reconstruction using a mons pubis pedicle flap. Potkul, R. K.; Barnes, W. A.; Barter, J. F.; Delgado, G.; Spear, S. L.; Gynecologic oncology